Ginger and Parkinson's Disease: Neuroprotection and Dopamine

Parkinson's disease, the second largest neurodegenerative disease in the world, involves progressive destruction of dopaminergic neurons in the substantia nigra. The ginger, thanks to its neuroprotective compounds, is the subject of growing scientific research.

Neuroprotective mechanisms of ginger

6-shogaol, a bioactive compound in ginger, has several documented neuroprotective properties:

• Anti-neuroinflammation : inhibits microglial activation (immune cells of the brain) which destroy dopamine neurons
• Brain Antioxidant : crosses the blood-brain barrier, reduces the cortisol-natural">ginger oxidative stress in the substantia nigra
• Mitochondrial protection : preserves the function of neuronal mitochondria (key target in Parkinson’s)

Promising preclinical studies

Studies on animal models (Neurochemical Research, 2019; Phytomedicine, 2021) show that ginger extract:

• Reduces dopamine neuron loss by 40-60% in MPTP models
• Improves behavioral markers (motor skills, coordination)
• Reduces the accumulation of α-synuclein (central protein of Parkinson's pathology)

Note: These studies are preclinical (animals). Human clinical trials are underway but direct evidence in humans remains limited.

Ginger as a complement to conventional treatments

Ginger is not a substitute for L-DOPA or dopamine agonists. It can be considered as additional support, in particular for:

• Reduceinflammation systemic (known aggravating factor)
• Improve the bloating-reflux-nausea">ginger and digestion (frequently disturbed in Parkinson's)
• Support general neuroprotection

INTI Drink: optimal bioavailability

The concentrated liquid form of INTI maximizes the absorption of ginger's bioactive compounds. no added sugar (1.19g/100ml vs ~34g for comparison INTI vs GIMBER) — important because chronic hyperglycemia aggravates neuroinflammation.

Consult a neurologist before any change in Parkinson’s treatment.